Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tullus

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activityE M D Smith, A Eleuteri, B Goilav, et al.
Clinical Immunology (Orlando, Fla.)|April 11, 2024
Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task forceE M D Smith, A Aggarwal, J Ainsworth, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2023
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)E M D Smith, A Aggarwal, J Ainsworth, et al.
Genes and Immunity|July 21, 2007
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5J-H Shin, M Janer, B McNeney, et al.
Genes and Immunity|June 8, 2007
SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patientsS K Sedimbi, X R Luo, C B Sanjeevi, et al.
Acta Diabetologica|September 5, 2008
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered riskSabina Resic-Lindehammer, K Larsson, E Ortqvist, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Clinical Immunology (Orlando, Fla.)|November 5, 2018
A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activityE M D Smith, A Eleuteri, B Goilav, et al.
Clinical Immunology (Orlando, Fla.)|April 11, 2024
Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task forceE M D Smith, A Aggarwal, J Ainsworth, et al.
Clinical Immunology (Orlando, Fla.)|March 19, 2023
PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)E M D Smith, A Aggarwal, J Ainsworth, et al.
Genes and Immunity|July 21, 2007
IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5J-H Shin, M Janer, B McNeney, et al.
Genes and Immunity|June 8, 2007
SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patientsS K Sedimbi, X R Luo, C B Sanjeevi, et al.
Acta Diabetologica|September 5, 2008
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered riskSabina Resic-Lindehammer, K Larsson, E Ortqvist, et al.
Pageof 9